Price movement over the last 24 hours
Archer-Daniels-Midland Co vs TransMedics Group Inc — how do they compare? Archer-Daniels-Midland Co trades at $80.4 (market cap $37.69B), while TransMedics Group Inc trades at $69.51 (market cap $2.46B). The key difference: Archer-Daniels-Midland Co is far larger — about 15.3× TransMedics Group Inc's market cap, and Archer-Daniels-Midland Co pays a 2.66% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| ADM | TMDX | |
|---|---|---|
Market Cap | $37.69B | $2.46B |
Sector | Consumer Staples | Technology |
52-Week High | $84.11 | $150.42 |
52-Week Low | $53.54 | $61.99 |
Enterprise Value | $47.72B | $2.86B |
Dividend Yield | 2.66% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TMDX trades at $71.23, up 3.44% on the day, but technical indicators signal a bearish trend. The company reported strong profitability with a 27.04% net income margin and 45.22% ROE for 2025, though Q1 2026 earnings missed expectations. Recent strategic investments in European organ logistics aim to expand its competitive moat, but margin pressure from expansion costs is a key concern noted by analysts (Zacks Investment Research, 2026-07-07).
The investment outlook is mixed: strong analyst consensus (75% buy ratings) and a $108.71 price target suggest significant upside, but near-term execution risks and bearish technicals warrant caution. Long-term growth drivers in transplant logistics are compelling, yet investors must weigh expansion costs against the potential for market share gains.
Trailing returns across standard periods
Latest headlines on both assets
Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. Additionally, the company owns an extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients. The company is also a large producer of corn-based sweeteners, starches, and ethanol.
Read more on ADM →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →